Joseph St. Laurent

Co-Chief Scientific Officer at Olatec Therapeutics

Joseph P. St. Laurent serves as the Olatec’s co-Chief Scientific Officer. Since July 2005, Mr. Laurent has been responsible for all aspects of the chemical drug development and analysis of dapansutrile and the OLT Analogues. Mr. St. Laurent is President and Chief Scientific Officer of Chemic Laboratories Inc., which he co-founded in 1998. Prior to establishing Chemic, Mr. St. Laurent served for 10 years in various technical and management roles at several New England contract research organizations. Mr. St. Laurent served as a research associate at the Eunice Kennedy Shriver Center, where his research surrounded the area of childhood genetic disorders (specifically those caused by abhorrent levels of lysosomal enzymes) and implications of outside influences on the causation of such disorders. Mr. St. Laurent’s educational credentials include a BS degree in Biology-Biochemistry from Bridgewater State College (now Bridgewater State University) in 1988; advanced postgraduate organic and physical chemistry studies at Bridgewater State College from 1988-1989; advanced studies in mass spectral data interpretation in 1991 at Analytical Education Center, Atlanta, Georgia; and management development studies at Suffolk University in 1991.

Links

Timeline

  • Co-Chief Scientific Officer

    Current role